Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, remains a significant health challenge, particularly in developing countries. This article aims to highlight recent advancements and best practices in the management of this disease, providing a comprehensive guide for healthcare professionals.
Accurate and prompt diagnosis of enteric fever is crucial. Conventional culture methods, though gold standard, are time-consuming and lack sensitivity. Advances in molecular diagnostics, such as Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS), offer rapid, sensitive, and specific detection of the causative organisms. These techniques also aid in identifying antibiotic resistance, crucial for effective treatment planning.
Antimicrobial resistance is a pressing concern in enteric fever management. The emergence of extensively drug-resistant (XDR) strains necessitates the use of newer antimicrobials. Azithromycin has shown effectiveness against multi-drug resistant strains, while newer agents like ceftriaxone and carbapenems are used for XDR strains. Vaccination remains a crucial preventative measure, with the newer Typhoid Conjugate Vaccines (TCV) showing promising results in reducing disease incidence.
Best practices include early diagnosis, appropriate use of antimicrobials, and preventive strategies. Clinicians should consider enteric fever in febrile patients with relevant travel or contact history. Empirical therapy should be guided by local antimicrobial resistance patterns. Vaccination, particularly TCV, should be promoted in high-risk populations. Additionally, improving sanitation and safe water supply are essential public health measures.
Managing enteric fever involves a multi-faceted approach, incorporating advancements in diagnostic techniques and treatment modalities. Adherence to best practices, including appropriate antimicrobial use and preventive measures, is crucial. Healthcare professionals play a pivotal role in combating this disease, through timely diagnosis, effective treatment, and patient education on preventive measures.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation